SELECTIVE ANDROGEN RECEPTOR MODULATOR
Ligandrol (LGD 4033) is an investigational selective androgen receptor modulator for treatments of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics.